Global
Human Nutrition

PREBILAC® 2'-FL

Mother’s Gift for Health Across All Life Stages

PREBILAC® is BASF’s brand of 2’-Fucosyllactose (2’-FL), a human-designed prebiotic. 2'-FL is a component of Human Milk Oligosaccharides (HMO), complex carbohydrates that are naturally present in breast milk. PREBILAC® is used in infant nutrition and dietary supplements to support the digestive and immune health of consumers.

intestine-cross-section.jpg
There is a connection between gut and immune health.

Research has shown that 2’-FL supports the development of a healthy gut and immune system, may lower the risk of allergy and plays a role in the development of normal brain functions and cognition in early life and beyond*. 

In the global dietary supplement market, digestive support is a growing segment. The causes and symptoms of digestive discomfort experienced by consumers are manifold. Drugs, diet and lifestyle and supplementation are various ways to manage digestive discomfort. 

Increasingly, consumers are also interested in finding ways to support immune health and showing stronger awareness of the connection between the gut and immune health.

Sources of 2’-FL

2’-FL is naturally found in human breast milk. BASF offers human-designed, nature-identical 2’-FL for wide applications.

Benefits of PREBILAC® 2'-FL

  • PREBILAC is a nature-identical prebiotic and patent-protected for the use as a prebiotic and as a modulator of inflammatory factors. 
  • With PREBILAC, tap on a growing market momentum of increasing consumer interest and access an expanding digestive health segment with product differentiation. PREBILAC offers ease of formulation with a neutral taste, good flowability and dissolution properties. 
  • BASF’s global network of application laboratories offers first-class application services, tailor-made training and technical support for infant nutrition, dietary supplements, as well as functional and medical nutrition. 

You may be interested in

* Patents covering these uses have been granted in Japan and the United States, while patent applications on these uses have been filed or sought in other markets.